Alzamend Neuro Inc (ALZN) — Financial statements
Income statement, balance sheet, and cash flow for Alzamend Neuro Inc — annual and quarterly history with growth and margin analysis.
| Metric (USD Millions) | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
| Revenue & Gross Profit | ||||||
| Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Cost of Revenue | 0.05 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Gross Profit | -0.05↑0.0% | -0.05↓120.0% | -0.02 | 0.00 | 0.00 | |
| Operating Expenses | ||||||
| R&D Expenses | 1↓78.1% | 6↓13.3% | 7↑43.2% | 5↑296.7% | 1 | |
| General & Administrative Expenses | 0.00↓100.0% | 3↓47.9% | 7↓6.1% | 7↑95.5% | 4 | |
| Selling & Marketing Expenses | 0.00 | 0.00↓100.0% | 0.74 | 0.00 | 0.00 | |
| SG&A Expenses | 3↓13.0% | 3↓53.1% | 7↑4.3% | 7↑95.5% | 4 | |
| Other Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Operating Expenses | 4↓55.3% | 10↓33.2% | 15↑20.7% | 12↑148.8% | 5 | |
| Total Costs & Expenses | 4↓54.8% | 10↓33.2% | 15↑20.7% | 12↑148.8% | 5 | |
| Operating Results | ||||||
| Operating Income | -4↑54.8% | -10↑33.2% | -15↓20.7% | -12↓148.8% | -5 | |
| Depreciation & Amortization | 0.05↑0.0% | 0.05↑120.0% | 0.02↑549.9% | 0.00↓99.9% | 5 | |
| EBITDA | -4↑55.0% | -10↑33.4% | -15↓20.6% | -12↓148.8% | -5 | |
| EBIT | -4↑54.8% | -10↑33.2% | -15↓20.7% | -12↓152.0% | -5 | |
| Interest & Other Income | ||||||
| Net Interest Income | -0.02↓78.5% | -0.01↓31.3% | -0.01↑83.4% | -0.05↑70.4% | -0.16 | |
| Interest Income | 0.00 | 0.00↓100.0% | 0.00↓83.4% | 0.00↓97.3% | 0.00 | |
| Interest Expense | 0.02↑78.5% | 0.01↑31.2% | 0.01↓83.4% | 0.05↓70.7% | 0.16 | |
| Non-Operating Income | 0.00 | 0.00 | 0.00↑100.0% | -0.00↑93.8% | -0.06 | |
| Other Income / Expenses | -0.02↓78.5% | -0.01↓31.2% | -0.01↑81.9% | -0.04↑55.1% | -0.09 | |
| Income Before Tax | -5↑54.6% | -10↑33.1% | -15↓20.4% | -12↓144.9% | -5 | |
| Income Tax Expense | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Net Income & EPS | ||||||
| Net Income from Continuing Operations | -5↑54.6% | -10↑33.1% | -15↓20.4% | -12↓144.9% | -5 | |
| Net Income from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Net Income | -5↑54.6% | -10↑33.1% | -15↓20.4% | -12↓144.9% | -5 | |
| Bottom-Line Net Income | -5↑48.7% | -10↑33.1% | -15↓20.4% | -12↓144.9% | -5 | |
| EPS (Basic) | -11.32↑91.4% | -132.33↑35.8% | -205.97↓10.0% | -187.31↓99.7% | -93.78 | |
| EPS (Diluted) | -11.32↑91.4% | -132.33↑35.8% | -205.97↓10.0% | -187.31↓99.7% | -93.78 | |
| Weighted Average Shares | 0.40↑430.7% | 0.08↑4.2% | 0.07↑10.8% | 0.07↑22.6% | 0.05 | |
| Weighted Average Diluted Shares | 0.45↑499.7% | 0.08↑4.1% | 0.07↑9.5% | 0.07↑22.6% | 0.05 | |
* All figures in Millions of USD, except per share data. Growth rates calculated Year-over-Year (YoY). Data source: SEC Filings.